The global biosurgery market is anticipated to grow at a CAGR of 6.8% during the forecast period (2021-2027). The key companies across the globe are focusing on the adoption of different growth strategies including capacity expansion, mergers and acquisitions, geographical expansion, new product launch, and product innovation to remain competitive in the marketplace. For instance, in September 2020, Takeda Pharmaceuticals co. ltd. has done an agreement with Corza Health Inc., to divest its TachoSil Fibrin Sealant Patch. This fibrin sealant patch is a surgical patch to deliver safe, fast, and reliable bleeding control. Takeda Pharmaceutical Company received around $421 million in cash for divesting its TachoSil to Corza Health.
To Request a Sample of our Report on Biosurgery Market: https://www.omrglobal.com/request-sample/biosurgery-market
Moreover, in September 2020, CryoLife, Inc., a cardiac and vascular surgery company focused on aortic disease, has announced that it has acquired Ascyrus Medical LLC, a Florida-based company. Ascyrus’s first aortic arch remodeling device named Ascyrus Medical Dissection Stent used for the treatment of Type A aortic dissections. Apart from it, in October 2018, Atrium Medical Corporation, a subsidiary of Getinge, has done an agreement to divest its biosurgery business to HJ Capital 1, the parent company of SeCQure Surgical Corporation, a medical device company.
In December 2019, Johnsons & Johnsons, a medical devices company, has announced that Ethicon has launched VISTASEAL Fibrin Sealant (Human) to assist surgeons to manage bleeding during surgery. It is a combination of fibrinogen and thrombin, clotting proteins found in human plasma. When applied to the bleeding portion, it forms adherent, and durable clots and assist to sustain hemostasis (stoppage of bleeding), even in high-risk patients. However, the key player’s strategies such as the expansion of its product distribution by making new agreements, launches of new products, and mergers and acquisitions in the market are to drive the global biosurgery market during the forecast period.
Market Coverage
· The market number available for – 2020-2027
· Base year- 2020
· Forecast period- 2021-2027
Segment Covered-
· By Product
· By Application
Regions Covered-
· North America
· Europe
· Asia-Pacific
· Rest of the World
· Competitive Landscape- Baxter International Inc., B. Braun Melsungen AG, Cohera Medical, Inc., CryoLife Inc., CSL Limited (CSL Behring), Johnson & Johnson (Ethicon, Inc.), among others
(Get 15% Discount on Buying this Report)
A full Report of Biosurgery Market is Available at: https://www.omrglobal.com/industry-reports/biosurgery-market
Global Biosurgery Market Report Segment
By Products
· Adhesion Barriers
· Soft Tissue Management (mesh/patch)
· Biological
· Synthetic
Bone graft substitutes
· Cell-based matrices
· Bone morphogenetic proteins
· Demineralized bone matrix
· Synthetic graft extender
Surgical Sealants
· Fibrin Sealants
· Collagen Based Adhesives
· Synthetic agents
· Tissue –Adhesive Glues
· Hemostatic Agents
· Staple Line Reinforcement Static Agents
By Application
· Neurological Surgeries
· General Surgeries
· Cardiovascular Surgeries
· Orthopedic Surgeries
· Gynecology Surgeries
· Urological Surgery
· Thoracic Surgeries
· Others (Ophthalmic Surgeries)
(This release has been published on OMR Industry Journal. OMR Industry Journal is not responsible for any content included in this release.)
